LEO Pharma appoints Leanne Walsh as general manager and vice president for UK and Ireland

Betsy Goodfellow | June 19, 2023 | Appointment | |  LEO Pharma, appointment, general manager, vice president 

Medical dermatology company LEO Pharma has announced that it has appointed Leanne Walsh as its new general manager and vice president for the UK and Ireland, having previously worked as general manager for Northern Europe at Aimmune Therapeutics.

Walsh has over 20 years of experience in the pharmaceutical industry at a global, European and affiliate level. In previous roles she has worked on and led various launches of novel therapies in competitive spaces, for complex, niche and specialist markets.

Commenting on her new role, Walsh stated: “I am excited to join the LEO Pharma UK and Ireland team. I firmly believe that LEO Pharma has the opportunity to be the preferred dermatology care partner and can exceed the expectations of both our partners and patients through transformation, dedication and a true partnership approach with all our stakeholders. […] My key priorities in this role are to drive proactive innovation and nurture an inclusive work environment where all internal and external stakeholders are inspired to take action to improve the lives of those living with skin conditions. The medical dermatology industry is evolving rapidly, which presents real opportunities for LEO Pharma, and I look forward to the exciting journey ahead.”

Walsh began her new role on 12 June 2023.

Related Content


LEO Pharma to acquire Timber Pharmaceuticals for up to $36m

Timber Pharmaceuticals has announced that it has entered a definitive agreement to be acquired by …


LEO Pharma’s delgocitinib hits main goals in moderate-to-severe chronic hand eczema

LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology …


Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Latest content